IntegraGen enters liquidation after court approves sale to ABL Diagnostics

Bitget2026/10/12 08:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Commercial court in Évry ordered IntegraGen SA into judicial liquidation on Oct. 9, 2026.
Court-approved sale transfers its genomics and bioinformatics services business to ABL Diagnostics, effective Oct. 9.
Deal price set at EUR 100,000, allocated to creditor repayments in the liquidation process.
Transaction includes the transfer of 16 employees.
Shares remain outstanding with no buyout; investors face potential partial or total loss as delisting is expected.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IntegraGen SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261012076105) on October 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

IntegraGen enters liquidation after court approves sale to ABL Diagnostics

You may also like

Crypto prices